Computational exploration of global venoms for antimicrobial discovery with Venomics artificial intelligence
The rise of antibiotic-resistant pathogens, particularly gram-negative bacteria, highlights the urgent need for novel therapeutics. Drug-resistant infections now contribute to approximately 5 million deaths annually, yet traditional antibiotic discovery has significantly stagnated. Venoms form an immense and largely untapped reservoir of bioactive molecules with antimicrobial potential. In this study, we mined global venomics datasets to identify new antimicrobial candidates. Using deep learning, we explored 16,123 venom proteins, generating 40,626,260 venom-encrypted peptides. From these, we identified 386 candidates that are structurally and functionally distinct from known antimicrobial peptides. They display high net charge and elevated hydrophobicity, characteristics conducive to bacterial-membrane disruption. Structural studies revealed that many of these peptides adopt flexible conformations that transition to α-helical conformations in membrane-mimicking environments, supporting their antimicrobial potential. Of the 58 peptides selected for experimental validation, 53 display potent antimicrobial activity. Mechanistic assays indicated that they primarily exert their effects through bacterial-membrane depolarization, mirroring AMP-like mechanisms. In a murine model of Acinetobacter baumannii infection, lead peptides significantly reduced bacterial burden without observable toxicity. Our findings demonstrate that venoms are a rich source of previously hidden antimicrobial scaffolds, and that integrating large-scale computational mining with experimental validation can accelerate the discovery of urgently needed antibiotics.
Authors
- Sufen Li
- César de la Fuente‐Núñez (ORCID: https://orcid.org/0000-0002-2005-5629)
- Changge Guan (ORCID: https://orcid.org/0000-0003-2531-6821)
- Marcelo D. T. Torres (ORCID: https://orcid.org/0000-0002-6165-9138)
Institutions
- University City Science Center (US)
- University of the Arts (US)
- Translational Therapeutics (United States) (US)
- Penn Center for AIDS Research (US)
- University of Pennsylvania (US)
- Philadelphia University (US)
Publication Details
- Journal
- Nature Communications
- Published
- 2025-07-12
- DOI
- https://doi.org/10.1038/s41467-025-60051-6
- Citations
- 19
- Primary Topic
- Antimicrobial Peptides and Activities
- Type
- article
- Field-Weighted Citation Impact
- 22.48
Funders
- Brain and Behavior Research Foundation
- University of Pennsylvania
- United Therapeutics Corporation
- Innovative Research Group Project of the National Natural Science Foundation of China
- National Institutes of Health
- Defense Threat Reduction Agency
- Perelman School of Medicine, University of Pennsylvania
- National Institute of General Medical Sciences